Drug Shortage Report for LOPROX
Report ID | 179123 |
Drug Identification Number | 02221810 |
Brand name | LOPROX |
Common or Proper name | LOPROX |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | CICLOPIROX OLAMINE |
Strength(s) | 1% |
Dosage form(s) | LOTION |
Route of administration | TOPICAL TOPICAL |
Packaging size | 60ml |
ATC code | D01AE |
ATC description | ANTIFUNGALS FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-02-01 |
Actual start date | 2023-01-05 |
Estimated end date | 2023-03-07 |
Actual end date | 2023-03-02 |
Shortage status | Resolved |
Updated date | 2023-03-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-03 | French | Compare |
v5 | 2023-03-03 | English | Compare |
v4 | 2023-01-11 | French | Compare |
v3 | 2023-01-11 | English | Compare |
v2 | 2022-12-21 | French | Compare |
v1 | 2022-12-21 | English | Compare |
Showing 1 to 6 of 6